Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5613-5625

  Connick, Elizabeth ^a   Folkvord, Joy M ^a   Lind, Katherine T ^a   Rakasz, Eva G ^b   Miles, Brodie ^a   Wilson, Nancy A ^b,f   Santiago, Mario L ^a   Schmitt, Kimberly ^c   Stephens, Edward B ^c   Kim, Hyeon O ^d   Wagstaff, Reece ^d   Li, Shengbin ^d   Abdelaal, Hadia M ^d,e   Kemp, Nathan ^d   Watkins, David I ^b,g   MaWhinney, Samantha ^a   Skinner, Pamela J ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Zagazig University   (Egypt)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; EPITOPE; VIRUS RNA; VIRUS ANTIGEN;

ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ASYMPTOMATIC INFECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; INTESTINE; LYMPH NODE; LYMPHOID TISSUE; NONHUMAN; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; VIRUS REPLICATION; ANIMAL; CELL CULTURE; CELL MOTION; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; CELL MOVEMENT; CELLS, CULTURED; DISEASE PROGRESSION; LYMPH NODES; MACACA MULATTA; RECEPTORS, CCR7; RECEPTORS, CXCR5; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 84912569301     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401161     Document Type: Article

References (62)

1. Connick, E., T. Mattila, J. M. Folkvord, R. Schlichtemeier, A. L. Meditz, M. G. Ray, M. D. McCarter, S. Mawhinney, A. Hage, C. White, and P. J. Skinner. 2007. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J. Immunol. 178: 6975-6983.
2. Folkvord, J. M., C. Armon, and E. Connick. 2005. Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res. Hum. Retroviruses 21: 363-370.
3. Hufert, F. T., J. van Lunzen, G. Janossy, S. Bertram, J. Schmitz, O. Haller, P. Racz, and D. von Laer. 1997. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS 11: 849-857.
4. Tenner-Racz, K., H. J. Stellbrink, J. van Lunzen, C. Schneider, J. P. Jacobs, B. Raschdorff, G. Grosschupff, R. M. Steinman, and P. Racz. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 187: 949-959.
5. Biberfeld, P., K. J. Chayt, L. M. Marselle, G. Biberfeld, R. C. Gallo, and M. E. Harper. 1986. HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am. J. Pathol. 125: 436-442.
6. Brenchley, J. M., C. Vinton, B. Tabb, X. P. Hao, E. Connick, M. Paiardini, J. D. Lifson, G. Silvestri, and J. D. Estes. 2012. Differential infection patterns of CD4 + T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood 120: 4172-4181.
7. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
8. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362: 355-358.
9. Heath, S. L., J. G. Tew, J. G. Tew, A. K. Szakal, and G. F. Burton. 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377: 740-744.
10. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
11. Connick, E., D. G. Marr, X. Q. Zhang, S. J. Clark, M. S. Saag, R. T. Schooley, and T. J. Curiel. 1996. HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res. Hum. Retroviruses 12: 1129-1140.
12. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655.
13. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162: 5127-5133.
14. Yasutomi, Y., K. A. Reimann, C. I. Lord, M. D. Miller, and N. L. Letvin. 1993. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67: 1707-1711.
15. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181: 1365-1372.
16. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142: 452-462.
17. Villada, I. B., L. Mortara, A. M. Aubertin, H. Gras-Masse, J. P. Lé vy, and J. G. Guillet. 1997. Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period. FEMS Immunol. Med. Microbiol. 19: 81-87.
18. Allen, T. M., D. H. O'Connor, P. Jing, J. L. Dzuris, B. R. Mothé, T. U. Vogel, E. Dunphy, M. E. Liebl, C. Emerson, N. Wilson, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.
19. Janssen, E. M., E. E. Lemmens, T. Wolfe, U. Christen, M. G. von Herrath, and S. P. Schoenberger. 2003. CD4 + T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856.
20. Vaccari, M., J. Mattapallil, K. Song, W. P. Tsai, A. Hryniewicz, D. Venzon, M. Zanetti, K. A. Reimann, M. Roederer, and G. Franchini. 2008. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8 + T cells induced by vaccination during CD4+ T-cell deficiency. J. Virol. 82: 9629-9638.
21. Jin, X., D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, L. Weinberger, et al. 1999. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virusinfected macaques. J. Exp. Med. 189: 991-998.
22. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8 + lymphocytes. Science 283: 857-860.
23. Matano, T., R. Shibata, C. Siemon, M. Connors, H. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72: 164-169.
24. Brodie, S. J., D. A. Lewinsohn, B. K. Patterson, D. Jiyamapa, J. Krieger, L. Corey, P. D. Greenberg, and S. R. Riddell. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5: 34-41.
25. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, et al. 1995. Transfer of HIV- 1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1: 330-336.
26. Lieberman, J., P. R. Skolnik, G. R. Parkerson, III, J. A. Fabry, B. Landry, J. Bethel, and J. Kagan. 1997. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood 90: 2196-2206.
27. Mitsuyasu, R. T., P. A. Anton, S. G. Deeks, D. T. Scadden, E. Connick, M. T. Downs, A. Bakker, M. R. Roberts, C. H. June, S. Jalali, et al. 2000. Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects. Blood 96: 785-793.
28. Kaufmann, D. E., M. Lichterfeld, M. Altfeld, M. M. Addo, M. N. Johnston, P. K. Lee, B. S. Wagner, E. T. Kalife, D. Strick, E. S. Rosenberg, and B. D. Walker. 2004. Limited durability of viral control following treated acute HIV infection. PLoS Med. 1: e36.
29. Autran, B., R. L. Murphy, D. Costagliola, R. Tubiana, B. Clotet, J. Gatell, S. Staszewski, N. Wincker, L. Assoumou, R. El-Habib, et al. 2008. Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452). AIDS 22: 1313-1322.
30. Goujard, C., F. Marcellin, H. Hendel-Chavez, M. Burgard, V. Meiffrédy, A. Venet, C. Rouzioux, Y. Taoufik, R. El Habib, M. Beumont-Mauviel, et al. 2007. Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study. AIDS Res. Hum. Retroviruses 23: 1105-1113.
31. Kinloch-de Loes, S., B. Hoen, D. E. Smith, B. Autran, F. C. Lampe, A. N. Phillips, L. E. Goh, J. Andersson, C. Tsoukas, A. Sonnerborg, et al. 2005. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J. Infect. Dis. 192: 607-617.
32. Markowitz, M., X. Jin, A. Hurley, V. Simon, B. Ramratnam, M. Louie, G. R. Deschenes, M. Ramanathan, Jr., S. Barsoum, J. Vanderhoeven, et al. 2002. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J. Infect. Dis. 186: 634-643.
33. Schooley, R. T., J. Spritzler, H. Wang, M. M. Lederman, D. Havlir, D. R. Kuritzkes, R. Pollard, C. Battaglia, M. Robertson, D. Mehrotra, et al. 2010. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J. Infect. Dis. 202: 705-716.
34. Tjernlund, A., J. Zhu, K. Laing, K. Diem, D. McDonald, J. Vazquez, J. Cao, C. Ohlen, M. J. McElrath, L. J. Picker, and L. Corey. 2010. In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected rhesus macaques. Retrovirology 7: 12.
35. Chakrabarti, L., P. Isola, M. C. Cumont, M. A. Claessens-Maire, M. Hurtrel, L. Montagnier, and B. Hurtrel. 1994. Early stages of simian immunodeficiency virus infection in lymph nodes: evidence for high viral load and successive populations of target cells. Am. J. Pathol. 144: 1226-1237.
36. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi,W. Lin, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68: 2362-2370.
37. Okoye, A., H. Park, M. Rohankhedkar, L. Coyne-Johnson, R. Lum, J. M.Walker, S. L. Planer, A. W. Legasse, A. W. Sylwester, M. Piatak, Jr., et al. 2009. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206: 1575-1588.
38. Loffredo, J. T., T. C. Friedrich, E. J. Leó n, J. J. Stephany, D. S. Rodrigues, S. P. Spencer, A. T. Bean, D. R. Beal, B. J. Burwitz, R. A. Rudersdorf, et al. 2007. CD8+ T cells from SIV elite controller macaques recognize Mamu- B∗08-bound epitopes and select for widespread viral variation. PLoS ONE 2: e1152.
39. Loffredo, J. T., J. Maxwell, Y. Qi, C. E. Glidden, G. J. Borchardt, T. Soma, A. T. Bean, D. R. Beal, N. A. Wilson, W. M. Rehrauer, et al. 2007. Mamu- B08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81: 8827-8832.
40. Folkvord, J. M., D. M. Anderson, J. Arya, S. MaWhinney, and E. Connick. 2003. Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue in vivo. J. Acquir. Immune Defic. Syndr. 32: 469-476.
41. Folkvord, J. M., M. D. McCarter, J. Ryder, A. L. Meditz, J. E. Forster, and E. Connick. 2006. α-Defensins 1, 2, and 3 are expressed by granulocytes in lymphoid tissues of HIV-1- seropositive and -seronegative individuals. J. Acquir. Immune Defic. Syndr. 42: 529-536.
42. Skinner, P. J., M. A. Daniels, C. S. Schmidt, S. C. Jameson, and A. T. Haase. 2000. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165: 613-617.
43. Allen, T. M., J. Sidney, M. F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, and D. I. Watkins. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A∗01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160: 6062-6071.
44. Loffredo, J. T., J. Sidney, A. T. Bean, D. R. Beal, W. Bardet, A. Wahl, O. E. Hawkins, S. Piaskowski, N. A. Wilson, W. H. Hildebrand, et al. 2009. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B∗08 and HLA-B∗2705, bind peptides with sequence similarity. J. Immunol. 182: 7763-7775.
45. Loffredo, J. T., J. Sidney, C. Wojewoda, E. Dodds, M. R. Reynolds, G. Napoé, B. R. Mothé, D. H. O'Connor, N. A. Wilson, D. I. Watkins, and A. Sette. 2004. Identification of seventeen new simian immunodeficiency virus-derived CD8 + T cell epitopes restricted by the high frequency molecule, Mamu-A∗02, and potential escape from CTL recognition. J. Immunol. 173: 5064-5076.
46. Hardtke, S., L. Ohl, and R. Förster. 2005. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 106: 1924-1931.
47. Reinhart, T. A., M. J. Rogan, G. A. Viglianti, D. M. Rausch, L. E. Eiden, and A. T. Haase. 1997. A new approach to investigating the relationship between productive infection and cytopathicity in vivo. Nat. Med. 3: 218-221.
48. Li, Q., L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller, and A. T. Haase. 2005. Peak SIV replication in resting memory CD4 + T cells depletes gut lamina propria CD4 + T cells. Nature 434: 1148-1152.
49. Zhang, Z., T. Schuler, M. Zupancic, S. Wietgrefe, K. A. Staskus, K. A. Reimann, T. A. Reinhart, M. Rogan, W. Cavert, C. J. Miller, et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
50. Di Mascio, M., C. H. Paik, J. A. Carrasquillo, J. S. Maeng, B. S. Jang, I. S. Shin, S. Srinivasula, R. Byrum, A. Neria, W. Kopp, et al. 2009. Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates. Blood 114: 328-337.
51. Ganusov, V. V., and R. J. De Boer. 2007. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 28: 514-518.
52. Lay, M. D., J. Petravic, S. N. Gordon, J. Engram, G. Silvestri, and M. P. Davenport. 2009. Is the gut the major source of virus in early simian immunodeficiency virus infection? J. Virol. 83: 7517-7523.
53. Petravic, J., T. H. Vanderford, G. Silvestri, and M. Davenport. 2013. Estimating the contribution of the gut to plasma viral load in early SIV infection. Retrovirology 10: 105.
54. Vanderford, T. H., C. Bleckwehl, J. C. Engram, R. M. Dunham, N. R. Klatt, M. B. Feinberg, D. A. Garber, M. R. Betts, and G. Silvestri. 2011. Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques. PLoS Pathog. 7: e1002048.
55. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
56. Stahl-Hennig, C., M. Eisenblatter, M. Franz, H. Stoiber, K. Tenner-Racz, Y. S. Suh, E. Jasny, B. Falkensammer, M. Ugucchioni, G. Georgsson, et al. 2007. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. Front. Biosci. 12: 2107-2123.
57. Minang, J. T., M. T. Trivett, L. V. Coren, E. V. Barsov, M. Piatak, Jr., D. E. Ott, and C. Ohlen. 2009. Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8+ T cells independent of IFN-g and CD107a responses. Virology 391: 130-139.
58. Schaerli, P., P. Loetscher, and B. Moser. 2001. Cutting edge: Induction of Follicular Homing Precedes Effector Th Cell Development. J. Immunol. 167: 6082-6086.
59. Elahi, S., T. Niki, M. Hirashima, and H. Horton. 2012. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood 119: 4192-4204.
60. Cubas, R. A., J. C. Mudd, A. L. Savoye, M. Perreau, J. van Grevenynghe, T. Metcalf, E. Connick, A. Meditz, G. J. Freeman, G. Abesada-Terk, Jr., et al. 2013. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat. Med. 19: 494-499.
61. Hofmeyer, K. A., H. Jeon, and X. Zang. 2011. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. J. Biomed. Biotechnol. 2011: 451694.
62. Fukazawa, Y., H. Park, M. J. Cameron, F. Lefebvre, R. Lum, N. Coombes, E. Mahyari, S. I. Hagen, J. Y. Bae, M. D. Reyes, III, et al. 2012. Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat. Med. 18: 1673-1681.